* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides pediatric inpatient and outpatient medical services. Clinic serving children from newborn to 18 years old.
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross Margin | 98.7% | 89.4% | 35.4% | 34.7% | 52.1% | 37.1% | 19.8% | 19.5% |
| EBITDA Margin | 25.6% | 34.4% | 22.7% | 23.5% | 45.6% | 17.1% | -11.1% | -2.5% |
| EBITDAR | 279 | 758 | 650 | 768 | 3,388 | 883 | -453 | -105 |
| EBITDAR Margin | 25.6% | 34.4% | 22.7% | 23.5% | 45.6% | 17.1% | -11.1% | -2.5% |
| EBIT Margin | 21.7% | 29.9% | 17.1% | 15.9% | 41.7% | 9.6% | -21.4% | -12.6% |
| Net Profit Margin | 34.8% | 26.9% | 15.1% | 16.6% | 37.8% | 6.5% | -23.7% | -15.9% |
| Operating Expense % of Sales | 73.1% | 55.0% | 12.7% | 11.1% | 6.4% | 20.0% | 30.9% | 21.9% |
| Returns | ||||||||
| Return on Assets (ROA) | 13.7% | 15.8% | 10.0% | 10.9% | 45.6% | 6.6% | -19.3% | -15.2% |
| Return on Equity (ROE) | 17.5% | 21.5% | 13.6% | 14.6% | 51.0% | 7.5% | -29.3% | -25.9% |
| ROIC [EBIT / Invested Capital] | 9.3% | 20.1% | 14.1% | 12.2% | 66.7% | 10.6% | -20.6% | -15.0% |
| Leverage & debt balances | ||||||||
| Debt-to-Assets | 15.9% | 15.1% | 16.8% | 11.7% | 4.0% | 4.7% | 19.6% | 21.8% |
| Debt-to-Equity | 0.20x | 0.21x | 0.23x | 0.16x | 0.04x | 0.05x | 0.30x | 0.37x |
| Debt-to-EBITDA | 1.58x | 0.75x | 1.12x | 0.76x | 0.07x | 0.27x | N/A | N/A |
| Equity-to-Assets | 78.4% | 73.5% | 73.7% | 74.7% | 89.4% | 88.5% | 65.9% | 58.8% |
| Net Debt | 379 | 517 | 285 | 532 | -858 | 201 | 924 | 957 |
| Cash & Equivalents | 61 | 51 | 441 | 51 | 1,102 | 36 | 58 | 14 |
| Total Debt | 440 | 568 | 726 | 583 | 244 | 237 | 982 | 971 |
| Liquidity & working capital | ||||||||
| Current Ratio | 0.16x | 0.87x | 1.31x | 1.43x | 4.61x | 2.61x | 0.80x | 0.67x |
| Quick Ratio | 0.16x | 0.87x | 1.21x | 1.27x | 4.61x | 2.61x | 0.80x | 0.67x |
| Cash Ratio | 0.11x | 0.05x | 0.39x | 0.04x | 1.69x | 0.06x | 0.03x | 0.01x |
| Total Current Assets | 90 | 870 | 1,487 | 1,808 | 3,008 | 1,513 | 1,363 | 1,239 |
| Total Current Liabilities | 550 | 996 | 1,137 | 1,265 | 653 | 579 | 1,705 | 1,837 |
| Inventory | N/A | N/A | 106 | 201 | N/A | N/A | N/A | N/A |
| Trade Receivables | 27 | 804 | 938 | 1,555 | 1,819 | 1,353 | 1,176 | 1,100 |
| Trade Payables | 109 | 345 | 149 | 445 | 115 | 131 | 541 | 700 |
| Net Working Capital | -460 | -126 | 350 | 543 | 2,355 | 934 | -342 | -598 |
| Net Working Capital % of Revenue | -42.2% | -5.7% | 12.2% | 16.6% | 31.7% | 18.1% | -8.4% | -14.1% |
| Trade Working Capital | -82 | 459 | 895 | 1,311 | 1,704 | 1,222 | 635 | 400 |
| Trade Working Capital % of Revenue | -7.5% | 20.9% | 31.2% | 40.1% | 23.0% | 23.7% | 15.6% | 9.4% |
| Change in Trade Working Capital | N/A | 541 | 436 | 416 | 393 | -482 | -587 | -235 |
| Turnover & efficiency | ||||||||
| Inventory Turnover | N/A | N/A | 17.49x | 10.62x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | 20.9 | 34.4 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 40.37x | 2.74x | 3.06x | 2.10x | 4.08x | 3.81x | 3.46x | 3.87x |
| Days Sales Outstanding (DSO) | 9.0 | 133.3 | 119.4 | 173.8 | 89.4 | 95.9 | 105.4 | 94.4 |
| Payables Turnover | 0.13x | 0.68x | 12.44x | 4.80x | 30.94x | 24.71x | 6.04x | 4.90x |
| Days Payable Outstanding (DPO) | 2841.8 | 540.5 | 29.3 | 76.1 | 11.8 | 14.8 | 60.5 | 74.6 |
| Cash Conversion Cycle | -2832.7 days | -407.1 days | 110.9 days | 132.0 days | 77.6 days | 81.1 days | 45.0 days | 19.8 days |
| Asset Turnover | 0.39x | 0.59x | 0.66x | 0.65x | 1.21x | 1.02x | 0.81x | 0.95x |
| Cash flow & dividends | ||||||||
| Operating Cash Flow | 298 | 258 | 459 | 348 | 2,957 | 861 | -160 | 197 |
| Free Cash Flow (OCF − Capex proxy) | 298 | -68 | 344 | -140 | 2,460 | 299 | -406 | 143 |
| Cash Conversion (OCF / EBITDA) | 106.8% | 34.0% | 70.6% | 45.3% | 87.3% | 97.5% | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →